SLC30A8 and type 2 diabetes mellitus: A human study in people with one R138X allele demonstrated that enhanced insulin secretory responsiveness to glucose, combined with enhanced proinsulin processing, links SLC30A8 LoF mutations and protection from developing T2D (5).